Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cantargia AB (publ) (ST: CANTA)

 
CANTA Technical Analysis
5
As on 9th May 2025 CANTA STOCK Price closed @ 1.63 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.69 & Strong Sell for SHORT-TERM with Stoploss of 3.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CANTASTOCK Price

Open 1.55 Change Price %
High 1.65 1 Day 0.08 5.16
Low 1.55 1 Week -0.01 -0.61
Close 1.63 1 Month 0.15 10.14
Volume 390320 1 Year -2.12 -56.53
52 Week High 5.00 | 52 Week Low 1.25
 
ST Sweden Most Active Stocks
FING-B 0.02 0.00%
HDW-B 0.00 %
ENERS 0.00 %
WYLD 0.04 0.00%
S2M 0.01 0.00%
QUIA 0.01 0.00%
SBB-B 3.85 -3.99%
IMMNOV 0.40 17.65%
LUNE 21.97 6.65%
QLINEA 0.04 0.00%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
SPIFF 0.04 33.33%
RAY-B 314.50 30.77%
RAY-B 314.50 30.77%
LIDDS 0.05 25.00%
SCOUT 0.22 22.22%
IMMNOV 0.40 17.65%
CHECK 9.40 17.50%
COINETHE 177.19 16.67%
ELIC 5.12 16.36%
 
ST Sweden Top Losers Stocks
BUFAB 81.74 -79.96%
SECI 0.01 -50.00%
SECI 0.01 -50.00%
ZICC 0.25 -34.21%
AUR 0.82 -31.67%
AUR 0.82 -31.67%
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
 
 
CANTA
Daily Charts		 CANTA
Intraday Charts		 Whats New @
Bazaartrend		 CANTA
Free Analysis
 
CANTA Important Levels Intraday
RESISTANCE1.82
RESISTANCE1.76
RESISTANCE1.72
RESISTANCE1.68
SUPPORT1.58
SUPPORT1.54
SUPPORT1.50
SUPPORT1.44
 
CANTA Forecast May 2025
Share
4th UP Forecast3.48
3rd UP Forecast2.89
2nd UP Forecast2.52
1st UP Forecast2.15
1st DOWN Forecast1.11
2nd DOWN Forecast0.74
3rd DOWN Forecast0.37
4th DOWN Forecast-0.22
 
CANTA Weekly Forecast
4th UP Forecast2.52
3rd UP Forecast2.23
2nd UP Forecast2.06
1st UP Forecast1.88
1st DOWN Forecast1.38
2nd DOWN Forecast1.20
3rd DOWN Forecast1.03
4th DOWN Forecast0.74
 
CANTA Forecast2025
4th UP Forecast9.45
3rd UP Forecast6.94
2nd UP Forecast5.39
1st UP Forecast3.84
1st DOWN Forecast-0.58
2nd DOWN Forecast-2.13
3rd DOWN Forecast-3.68
4th DOWN Forecast-6.19
 
 
CANTA Other Details
Segment EQ
Market Capital 1699273216.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CANTA Address
CANTA
 
CANTA Latest News
 
Your Comments and Response on Cantargia AB (publ)
 
CANTA Business Profile
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the tumor inflammation that is driven by the Interleukin-1 system and is under phase1 clinical trial; and CAN10, an antibody against IL1RAP for treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis, and is under preclinical trial. It is also developing CANxx antibodies against IL1RAP that have other properties than CAN04 and CAN10. The company has collaboration agreements with Patheon Biologics BV and BioWa Inc. for the manufacture and production of CAN04; and Specialized Medical Services-oncology BV for the clinical study of CAN04. Cantargia AB (publ) was founded in 2010 and is based in Lund, Sweden. Address: ScheelevAegen 2, Lund, Sweden, 223 63
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service